These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4080297)

  • 1. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
    Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
    Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon in the treatment of multiple myeloma].
    Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
    Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].
    Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H
    Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of human recombinant interferon-alpha-2C in essential thrombocythaemia.
    Velu T; Delwiche F; Gangji D; Monsieur R; Flament J; Stryckmans P; Wybran J; Bellens R
    Oncology; 1985; 42 Suppl 1():10-4. PubMed ID: 4080296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.
    Ludwig H; Cortelezzi A; Scheithauer W; Van Camp BG; Kuzmits R; Fillet G; Peetermans M; Polli E; Flener R
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1111-6. PubMed ID: 3536528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy in the myeloproliferative disorders: the current options.
    Giles FJ
    Br J Haematol; 1991 Oct; 79 Suppl 1():92-5. PubMed ID: 1931719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
    Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
    Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The polychemotherapy of patients with multiple myeloma].
    Abdulkadyrov KM; Bessmel'tsev SS
    Vopr Onkol; 1992; 38(3):345-51. PubMed ID: 1300725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma.
    Preis P; Scheithauer W; Fritz E; Zielinski C; Kuehrer I; Cortelezzi A; Polli E; Baldini L; Pirker R; Kriegisch A
    Onkologie; 1989 Feb; 12(1):27-9. PubMed ID: 2654788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.
    Scheithauer W; Cortelezzi A; Fritz E; Kührer I; Polli E; Baldini L; Ludwig H
    J Biol Response Mod; 1989 Apr; 8(2):109-15. PubMed ID: 2659740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of essential thrombocythaemia by alpha 2a interferon.
    Bellucci S; Harousseau JL; Brice P; Tobelem G
    Lancet; 1988 Oct; 2(8617):960-1. PubMed ID: 2902403
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha interferon raises serum beta-2-microglobulin in patients treated for thrombocythaemia.
    Remes K; Tienhaara A; Pelliniemi TT
    Br J Haematol; 1993 Jun; 84(2):353-5. PubMed ID: 8398845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon.
    Kobayashi T; Sato Y; Hasegawa Y; Nagasawa T; Yoda Y; Abe T
    Intern Med; 1992 Jul; 31(7):936-40. PubMed ID: 1450506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment Group.
    Peest D; Deicher H; Coldewey R; Leo R; Bartl R; Bartels H; Braun HJ; von Broen IM; Fischer JT; Gramatzki M
    Onkologie; 1990 Dec; 13(6):458-60. PubMed ID: 2092283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon therapy for essential thrombocythaemia.
    Giles FJ; Singer CR; Gray AG; Yong KL; Brozovic M; Davies SC; Grant IR; Hoffbrand AV; Machin SJ; Mehta AB
    Lancet; 1988 Jul; 2(8602):70-2. PubMed ID: 2898699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia.
    Abegg-Werter MJ; Raemaekers JM; de Pauw BE; Haanen C
    Blut; 1990 Jan; 60(1):37-40. PubMed ID: 2105111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha-2a interferon (alpha-IFN) in the treatment of essential thrombocythaemia. Preliminary report.
    Gugliotta L; Macchi S; Catani L; Chetti L; Mattioli Belmonte M; Guarini A; Criscuolo D; Tura S
    Haematologica; 1987; 72(3):277-9. PubMed ID: 3114099
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis.
    Talpaz M; Kurzrock R; Kantarjian H; O'Brien S; Gutterman JU
    Am J Med; 1989 May; 86(5):554-8. PubMed ID: 2712063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of interferon in the treatment of multiple myeloma.
    Costanzi JJ; Pollard RB
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):24-8. PubMed ID: 3296211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha-induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosis.
    Chott A; Gisslinger H; Thiele J; Fritz E; Linkesch W; Radaszkiewicz T; Ludwig H
    Br J Haematol; 1990 Jan; 74(1):10-6. PubMed ID: 2310690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.